Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 2660917)

Published in Biomed Pharmacother on January 01, 1989

Authors

B Bannwarth1, P Netter, J Pourel, R J Royer, A Gaucher

Author Affiliations

1: Département de Pharmacologie, URA CNRS 1288, Faculté de Médecine de Nancy, France.

Associated clinical trials:

Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction | NCT00026819

Articles by these authors

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36

EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59

Mitochondrial genetics. I. Methodology and phenomenology. Symp Soc Exp Biol (1970) 2.92

Mitochondrial nucleic acids in the petite colonie mutants: deletions and repetition of genes. Biochimie (1973) 2.45

Mitochondrial genetics. VI. The petite mutation in Saccharomyces cerevisiae: interrelations between the loss of the p+ factor and the loss of the drug resistance mitochondrial genetic markers. Genetics (1974) 2.05

Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage (2006) 1.77

Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum (1997) 1.64

Critical sequences within mitochondrial introns: cis-dominant mutations of the "cytochrome-b-like" intron of the oxidase gene. Cell (1982) 1.59

Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis (2006) 1.59

Unsuspected prophage-like elements in Salmonella typhimurium. Mol Microbiol (1997) 1.56

Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res (1995) 1.55

Autosomal dominant spondyloarthropathy. N Engl J Med (1989) 1.54

Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet (1988) 1.50

Delayed methotrexate pneumonitis in rheumatoid arthritis. J Rheumatol (1991) 1.50

Fluoride and vertebral fractures. Lancet (1990) 1.48

Adverse drug reaction monitoring: doing it the French way. Lancet (1985) 1.41

Mitochondrial antibiotic resistance in yeast: ribosomal mutants resistant to chloramphenicol, erythromycin and spiramycin. Biochim Biophys Acta (1973) 1.41

Stereoselective distribution of tiaprofenic acid in synovium and cartilage in osteoarthritic patients. Eur J Clin Pharmacol (1996) 1.40

Fluoroquinolone induced arthralgia and magnetic resonance imaging. J Rheumatol (1996) 1.38

Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum (2001) 1.35

Analysis of intrachromosomal duplications in yeast Saccharomyces cerevisiae: a possible model for their origin. Mol Biol Evol (2000) 1.32

Mechanism of 3' splice site selection by the catalytic core of the sunY intron of bacteriophage T4: the role of a novel base-pairing interaction in group I introns. Genes Dev (1990) 1.32

Origin and fate of repeats in bacteria. Nucleic Acids Res (2002) 1.30

Long-term disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors. Arthritis Rheum (1990) 1.25

Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol (1992) 1.24

Evaluation of the effect of three surface treatments on the biocompatibility of 316L stainless steel using human differentiated cells. Biomaterials (1996) 1.23

Magnetic resonance imaging in osteoarthritis: which method best reflects synovial membrane inflammation? Correlations with clinical, macroscopic and microscopic features. Osteoarthritis Cartilage (2009) 1.21

Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol (1995) 1.21

Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway. FEBS Lett (2002) 1.21

Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes. J Biol Chem (2000) 1.21

Mitochondrial genetics. XI. Mutations at the mitochondrial locus omega affecting the recombination of mitochondrial genes in Saccharomyces cerevisiae. Mol Gen Genet (1976) 1.20

Study of intrachromosomal duplications among the eukaryote genomes. Mol Biol Evol (2001) 1.20

Scanning electron microscopic study of microcrystals implicated in human rheumatic diseases. Scan Electron Microsc (1980) 1.20

Mitochondrial genetics. VII. Allelism and mapping studies of ribosomal mutants resistant to chloramphenicol, erythromycin and spiramycin in S. cerevisiae. Genetics (1974) 1.19

[Hepatitis caused by non-steroidal anti-inflammatory agents. A cooperative evaluation of regional centers of drug surveillance for 1985]. Therapie (1988) 1.19

Molecular basis of the 'box effect', A maturase deficiency leading to the absence of splicing of two introns located in two split genes of yeast mitochondrial DNA. Eur J Biochem (1984) 1.15

Accuracy of respiratory rate monitoring using a non-invasive acoustic method after general anaesthesia. Br J Anaesth (2012) 1.15

[A controlled clinical trial for testing the efficacy of the homeopathic drug eupatorium perfoliatum D2 inthe treatment of common cold (author's transl)]. Arzneimittelforschung (1981) 1.14

Low incidence of rheumatoid arthritis in France. Scand J Rheumatol (1994) 1.11

Hereditary diffuse articular chondrocalcinosis. Dominant manifestation without close linkage with the HLA system in a large pedigree. Scand J Rheumatol (1977) 1.09

Insufficiency fractures of the ilium. Rev Rhum Engl Ed (1997) 1.09

Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation. Arthritis Rheum (1999) 1.07

Dialysis-associated arthropathy: a multicentre survey of 171 patients receiving haemodialysis for over 10 years. The Co-operative Group on Dialysis-associated Arthropathy. Br J Rheumatol (1992) 1.06

[Are coffee and alcohol consumption risk factors in pregnancy? (author's transl)]. Geburtshilfe Frauenheilkd (1974) 1.06

Stimulation of proteoglycan synthesis by glucuronosyltransferase-I gene delivery: a strategy to promote cartilage repair. Proc Natl Acad Sci U S A (2004) 1.05

Features of tendon disorders with fluoroquinolones. Therapie (1994) 1.05

Pefloxacin-induced achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrob Agents Chemother (2000) 1.03

Interaction between cyclosporin and erythromycin in a kidney transplant patient. Eur J Clin Pharmacol (1986) 1.02

[Measurement of the functional capacity in rheumatoid polyarthritis: a French adaptation of the Health Assessment Questionnaire (HAQ)]. Rev Rhum Mal Osteoartic (1991) 1.02

Monocrystalline calcium hydrogen phosphate dihydrate in destructive arthropathies of chondrocalcinosis. Lancet (1977) 0.99

Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum (1996) 0.99

Expression of the mitochondrial split gene coding for cytochrome oxidase subunit I in S. cerevisiae: RNA splicing pathway. Curr Genet (1986) 0.99

Psychosocial stress in tree shrews: clomipramine counteracts behavioral and endocrine changes. Pharmacol Biochem Behav (1996) 0.99

Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis. Osteoarthritis Cartilage (2004) 0.98

Aseptic loosening of cemented total arthroplasties of the hip in relation to positioning of the prosthesis. New utilization of the Tschuprow-Cramer statistical test. Acta Orthop Scand (1981) 0.97

Tuberculosis of the patella. Arch Orthop Trauma Surg (2003) 0.97

Sodium alginate sponges with or without sodium hyaluronate: in vitro engineering of cartilage. J Biomed Mater Res (2001) 0.97

Hepatitis induced by non-steroidal anti-inflammatory drugs. Ann Rheum Dis (1989) 0.97

[Toxicity and pharmacokinetics of zirconium oxychloride in mice and rats]. J Pharmacol (1984) 0.96

Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease. Am J Hum Genet (1999) 0.96

Functional disability in rheumatoid arthritis: two different models in early and established disease. J Rheumatol (1992) 0.96

Potassium chloride tablets and small bowel stenoses and perforations: two studies in the French Pharmacovigilance system. Am J Gastroenterol (1994) 0.96

Intragenic suppressors reveal long distance interactions between inactivating and reactivating amino acid replacements generating three-dimensional constraints in the structure of mitochondrial cytochrome b. J Biol Chem (1990) 0.95

Validity and discriminant ability of the HAQ Functional Index in early rheumatoid arthritis. Disabil Rehabil (1992) 0.95

Cytocompatibility of Ti-6Al-4V and Ti-5Al-2.5Fe alloys according to three surface treatments, using human fibroblasts and osteoblasts. Biomaterials (1996) 0.95

Tendon disorders with fluoroquinolones. Therapie (1997) 0.95

A comparative study of duplications in bacteria and eukaryotes: the importance of telomeres. Mol Biol Evol (1997) 0.95

Plasma and cerebrospinal fluid concentrations of indomethacin in humans. Relationship to analgesic activity. Eur J Clin Pharmacol (1990) 0.94

Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. Am J Physiol (1997) 0.94

[Determination of the best diagnostic criteria of sacroiliitis with MRI]. J Radiol (1999) 0.94

[Spondylarthropathies or ossifying polyenthesitis. Scintigraphic and scanographic evidence]. Rev Rhum Mal Osteoartic (1987) 0.93

Total and free ketoprofen in serum and synovial fluid after intramuscular injection. Clin Pharmacol Ther (1987) 0.93

Magnetic resonance imaging may be an asset to diagnose and classify fluoroquinolone-associated Achilles tendinitis. Fundam Clin Pharmacol (1995) 0.93

Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy. Osteoporos Int (1998) 0.92

Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families. Arthritis Rheum (1995) 0.92

Effect of articular cartilage proteoglycan depletion on high frequency ultrasound backscatter. Osteoarthritis Cartilage (2002) 0.92

Assessment of articular cartilage and subchondral bone: subtle and progressive changes in experimental osteoarthritis using 50 MHz echography in vitro. J Bone Miner Res (1997) 0.92

[The effects of paternal cigarette smoking on perinatal mortality and the incidence of malformations (author's transl)]. Dtsch Med Wochenschr (1974) 0.91

Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes. Osteoarthritis Cartilage (2006) 0.91

Evaluation of acoustical parameter sensitivity to age-related and osteoarthritic changes in articular cartilage using 50-MHz ultrasound. Ultrasound Med Biol (1998) 0.91

Changes in cortisol secretion during shiftwork: implications for tolerance to shiftwork? Ergonomics (1998) 0.91

HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis. Ann Rheum Dis (1985) 0.91

Hypoglycaemia induced by cibenzoline. Lancet (1988) 0.90

Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant. J Pediatr (1979) 0.90

Spiramycin does not increase plasma cyclosporin concentrations in renal transplant patients. Eur J Clin Pharmacol (1988) 0.90

Structure/function of the human Ga1beta1,3-glucuronosyltransferase. Dimerization and functional activity are mediated by two crucial cysteine residues. J Biol Chem (2000) 0.90